Janssen-Cilag has sought expanded European Medicines Agency (EMA) approval for TREMFYA to treat active ulcerative colitis and ...

Emergent also said it will shut down two of its US-based complexes – a drug substance manufacturing facility in Baltimore and ...

As the obesity space becomes more congested, clinical trial recruitment has become a larger issue for small biotechs.

Pfizer’s reported net income stood at $3.11bn in Q1 2024, marking a decrease of 44% from $5.54bn posted in the same period of ...

Under the terms of the deal, Mariana will receive $1bn and up to $750m in additional milestone payments from Novartis.

Novo Nordisk reported DKr61bn ($8.7bn) in sales from its diabetes and obesity portfolio, accounting for 93.3% of the total ...

Discover Vertex Pharmaceuticals' groundbreaking patent for compounds treating alpha-1 antitrypsin deficiency. Explore formula (I) derivatives and tailored compositions for precision medicine.

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

Discover Astellas Pharma's patented carbocyclic prolinamide derivatives for treating eye diseases like macular degeneration. Explore the unique compound structure and potential applications in ...

Discover how Agenus Inc's groundbreaking patent for antibodies targeting TIM-3 is revolutionizing therapeutic antibody development. Explore the specific amino acid sequences and methods for efficient ...

Poseida focuses on progressing cell and gene therapies that have the potential to cure cancers and rare diseases. Credit: ...

AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect ...